News Industry News Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting October 11, 2015
News Conference News TCT 2015 Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR October 11, 2015
News Industry News Tamir Wolf, MD, PhD Joins the Cardiovascular Research Foundation as Senior Director, Operations and Development for the CRF Clinical Trials Center October 08, 2015
News Daily News Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD L.A. McKeown October 05, 2015
News Industry News Medtronic's Valiant® Thoracic Stent Graft System Demonstrates Durability After Five Years October 05, 2015
News Daily News In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers October 01, 2015
News Daily News Sheathless Guide Catheter Safe, Effective in Transradial Primary PCI Yael L. Maxwell September 30, 2015
News Daily News UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible L.A. McKeown September 16, 2015
News Daily News Registry Data Show Low Complication Rates With Open Surgical Access for Transfemoral TAVR Todd Neale September 14, 2015
News Conference News ESC 2015 Registry Provides Support for Use of MitraClip in Lower-Risk Patients L.A. McKeown September 01, 2015
News Daily News A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR Yael L. Maxwell August 30, 2015
News Daily News Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR August 25, 2015
News Daily News Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR August 20, 2015
News Daily News Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía L.A. McKeown August 19, 2015
News Daily News CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery L.A. McKeown August 19, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015